Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI)

CUSIP: 68236X100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding
99,175,922
Total 13F shares
13,916,345
Share change
-7,997,340
Total reported value
$7,656,692
Price per share
$0.55
Number of holders
37
Value change
-$4,490,020
Number of buys
16
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 68236X100?
CUSIP 68236X100 identifies TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) as of Q2 2023

As of 30 Jun 2023, Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,916,345 shares. The largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, JOSH ARNOLD INVESTMENT CONSULTANT, LLC, Triatomic Management LP, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Saba Capital Management, L.P., and BlackRock Inc.. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.